Journals / Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.) / 2013 / Cilt: 24 - Sayı: 2

A comparison of the measurements with biochemical markers of bone turnover and bone mineral density in the assessment of the efficiency of osteoporosis treatment

Osteporoz tedavisinin etkinliğinin değerlendirilmesinde kemik döngüsü biyokimyasal belirteçleri ve kemik mineral yoğunluğu ölçümlerinin karşılaştırılması

Pages
82–86
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Urine NTx values respond to osteoporosis treatment faster than BMD measurements; thereby it may be suitable to use this parameter for the monitorization of the treatment efficiency.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to compare the measurements using biochemical markers of bone turnover and bone mineral density (BMD) in the assessment of the efficiency of osteoporosis treatment.
📊
Key Findings & Data:Patients and methods: Between March 2006 and December 2008, 166 patients with osteoporosis in our clinic were included.
💡
Conclusion & Impact:Conclusion: Urine NTx values respond to osteoporosis treatment faster than BMD measurements; thereby it may be suitable to use this parameter for the monitorization of the treatment efficiency.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to compare the measurements using biochemical markers of bone turnover and bone mineral density (BMD) in the assessment of the efficiency of osteoporosis treatment. Patients and methods: Between March 2006 and December 2008, 166 patients with osteoporosis in our clinic were included. Patients who were out of contact due to death or other reasons during follow-up were excluded. We compared the measurements of urinary biochemical markers of bone turnover using cross-linked N-telopeptide (Ntx) values and BMD in 60 patients (49 females, 11 males; mean age: 65.7 years; range: 42 to 87 years) with osteoporosis who were treatment-naive and completed study. Results: Twenty-nine (48.3%) of the patients received surgical treatment, while 31 (51.7%) received conservative therapy. Urine NTx values of the patients decreased 38.82% at three months; 51.99% at six months and 66.41% at 12 months. Lumbar vertebra BMD increased by 20.7% and femur neck BMD increased by 11.9% at the end of the first year. Conclusion: Urine NTx values respond to osteoporosis treatment faster than BMD measurements; thereby it may be suitable to use this parameter for the monitorization of the treatment efficiency.

Özet

Amaç: Bu çalışmada osteoporoz tedavisinin etkinliğinin değerlendirilmesinde kemik döngüsü biyokimyasal belirteçleri ve kemik mineral yoğunluğu (KMY) ölçümleri karşılaştırıldı.Hastalar ve yöntemler: Mart 2006 - Aralık 2008 tarihleri arasında kliniğimizde osteoporozlu 166 hasta çalışmaya alındı. Takiplerde ölüm ya da başka nedenlerle kontrolleritamamlanamayan hastalar çalışmadan çıkarıldı. Daha önceherhangi bir osteoporoz tedavisi almamış olan ve çalış-mayı tamamlayan osteoporozlu 60 hastanın (49 kadın, 11erkek; ort. yaş 65.7 yıl; dağılım 42-87 yıl) KMY ölçümleriile çapraz bağlı N-telopeptid (NTx) değerleri kullanılarak idrarda kemik döngüsü biyokimyasal belirteçleri ölçümlerikarşılaştırıldı. Bulgular: Hastaların 29’una (%48.3) cerrahi tedavi, 31’ine(%51.7) konservatif tedavi uygulandı. Hastaların ölçülenidrar NTx değerlerinde 3. ayda %38.82; 6. ayda %51.99; 12. ayda %66.41 azalma saptandı. Lomber vertebra KMY bir yılsonunda %20.7 artarken, femur boyun KMY’de %11.9 artışsaptandı.Sonuç: İdrar NTx değeri, KMY ölçümlerine kıyasla, oste oporoz tedavisine daha hızlı yanıt verdiği için, bu parametrenin tedavi etkinliğinin izleminde kullanılması uygunolabilir.

🔖

Cite This Article

SARIKAYA, B., GÜL, O., ÖZTÜRK, B. Y., ÖZGÜROL, B., GÖRMELİ, G., ATAOĞLU, M. B., ATİK, O. Ş. (2022). A comparison of the measurements with biochemical markers of bone turnover and bone mineral density in the assessment of the efficiency of osteoporosis treatment. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), Cilt: 24 - Sayı: 2, 82–86. https://ajindex.com/articles/498611

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Atik OS, Gunal I, Korkusuz F. Burden of osteoporosis. Clin Orthop Relat Res 2006;443:19-24
  2. Atik OS, Uslu MM, Eksioglu F, Satana T. Etiology of senile osteoporosis: a hypothesis. Clin Orthop Relat Res 2006;443:25-7
  3. Atik OS. Is the bone and joint decade over? Eklem Hastalik Cerrahisi 2010;21:123
  4. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129
  5. Gül O, Atik OS, Erdoğan D, Göktaş G. Is bone microstructure different between osteopenic and osteoporotic patients with femoral neck fracture?. [Article in Turkish] Eklem Hastalik Cerrahisi 2012;23:15-9
  6. Available from: http://www.osteomark.com/osteomark_ ntx/urine_elisa.aspx [Accessed 2011] 7. Atik OS. Is DXA the gold standard? [Article in English, Turkish] Eklem Hastalik Cerrahisi 2011;22:63
  7. Takakuwa M, Otsuka K, Konishi M, Itabashi K. Evaluation of the effect of 4 months of risedronate therapy on femoral strength using femoral strength analysis tools. J Int Med Res 2009;37:1972-81
  8. Finkelstein JS, Wyland JJ, Lee H, Neer RM. Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 2010;95:1838-45. doi: 10.1210/jc.2009-1703
  9. Hwang JS, Liou MJ, Ho C, Lin JD, Huang YY, Wang CJ, et al. The effects of weekly alendronate therapy in Taiwanese males with osteoporosis. J Bone Miner Metab 2010;28:328- 33. doi: 10.1007/s00774-009-0136-9. 11. van der Voort DJ, Geusens PP, Dinant GJ. Risk factors for osteoporosis related to their outcome: fractures. Osteoporos Int 2001;12:630-8
  10. Delmas PD. Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs. Osteoporos Int 2000;11 Suppl 6:S66-76
  11. Taguchi Y, Gorai I, Zhang MG, Chaki O, Nakayama M, Minaguchi H. Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides. Calcif Tissue Int 1998;62:395-9
  12. Greenspan SL, Resnick NM, Parker RA. Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo- controlled, randomized clinical trial. J Clin Endocrinol Metab 2005;90:2762-7
  13. Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, et al. Positive effect of